Clinical trial Recruiting at 1 site Observational Ages 21 to 65

Examining gut microbiota changes in patients undergoing metabolic surgery

Official title: The Gut Microbiota in Metabolic Surgery: A Multi-Ethnic, Multi-Omic, Longitudinal Study

Run by Vanderbilt University Medical Center · NCT05000996 · Data updated 2026-11-12

This study is testing how metabolic surgery affects gut bacteria and heart health in patients, especially focusing on the African American community, over the next 10 years.

Quick facts

Study typeObservational
Ages21 Years to 65 Years
SexAll
Enrollment300 (estimated)
SponsorVanderbilt University Medical Center
Academic / other
Drugs / interventionsChemotherapy
Locations1 site (Nashville, Tennessee)
StatusRecruiting
StartedAugust 19, 2021
Main results expectedDecember 31, 2028
Study endsJanuary 1, 2035
Registry record updatedNovember 9, 2026
Trial IDNCT05000996 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals approved for metabolic surgery who have a history of type 2 diabetes, hypertension, or dyslipidemia.

Probably not a fit

Patients with prior gastric operations, certain cardiovascular conditions, or current gastrointestinal diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study investigates the impact of metabolic surgery on gut microbiota and its relationship with cardiometabolic health outcomes. By enrolling up to 300 patients scheduled for metabolic surgery at Vanderbilt University Medical Center, the study aims to track changes in gut microbiota from pre-surgery to post-surgery over a period of up to 10 years. The research will utilize multi-omics approaches to analyze stool, blood, and tissue samples, focusing particularly on the underrepresented African American population with high rates of cardiometabolic diseases. The goal is to fill existing research gaps and better understand how gut microbiota influences surgical outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and management of obesity-related metabolic diseases, enhancing surgical outcomes for patients.

How similar studies have gone: While there is limited research on the specific relationship between gut microbiota and metabolic surgery outcomes, similar studies have shown promising results in understanding microbiota's role in metabolic health.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Be approved and scheduled for metabolic surgery at the Vanderbilt University Medical Center
* Have a history of type 2 diabetes, hypertension, or dyslipidemia
* Be able and willing to provide personal information and biological samples needed for the study

Exclusion Criteria:

* Prior gastric operations
* A history of coronary artery disease, stroke, heart failure, HIV infection, or untreated viral hepatitis
* Chemotherapy or radiotherapy for cancer within 2 years
* Current inflammatory bowel disease or celiac disease
* Vomiting, constipation, or diarrhea within 7 days or use of antibiotics within 2 months

Where it's running

  • Vanderbilt_University MC
    Nashville, Tennessee, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.